MARKET

PODD

PODD

Insulet
NASDAQ

Real-time Quotes | Nasdaq Last Sale

259.10
-3.57
-1.36%
After Hours: 259.10 0 0.00% 16:51 02/26 EST
OPEN
265.81
PREV CLOSE
262.67
HIGH
270.27
LOW
258.31
VOLUME
698.13K
TURNOVER
--
52 WEEK HIGH
298.43
52 WEEK LOW
121.00
MARKET CAP
17.08B
P/E (TTM)
2578.11
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
DJ Insulet Price Target Raised to $277.00/Share From $235.00 by Oppenheimer
Dow Jones · 1d ago
Robert W. Baird Sticks to Their Buy Rating for Insulet (PODD)
In a report released yesterday, Jeff Johnson from Robert W. Baird reiterated a Buy rating on Insulet (PODD). The company's shares closed last Thursday at
SmarterAnalyst · 1d ago
--Analyst Actions: Oppenheimer Adjusts Insulet PT to $277 From $235, Maintains Perform Rating
MT Newswires · 1d ago
--Analyst Actions: UBS Adjusts Insulet's Price Target to $267 From $245 After Q4 Sales Beat; Neutral Rating Kept
MT Newswires · 1d ago
Electronic Drug Delivery Systems Market Industry Size, Trends, Growth, Development, Report and Forecast 2020-2027
Japan, Japan, Thu, 25 Feb 2021 04:15:09 / Comserve Inc. / -- Competitive Analysis: Bayer AG, Gerresheimer AG, Medtronic PLC, Elcam Medical Group, Novo...
Comserve · 1d ago
Top Healthcare Stocks for March 2021
These are the healthcare stocks with the best value, fastest growth, and most momentum for March 2021.
Investopedia · 2d ago
DJ Insulet Price Target Raised to $296.00/Share From $282.00 by Raymond James
Dow Jones · 2d ago
DJ Insulet Is Maintained at Outperform by Raymond James
Dow Jones · 2d ago
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of PODD. Analyze the recent business situations of Insulet through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 20 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average PODD stock price target is 280.31 with a high estimate of 323.00 and a low estimate of 250.00.
EPS
Institutional Holdings
Institutions: 645
Institutional Holdings: 75.11M
% Owned: 113.92%
Shares Outstanding: 65.93M
TypeInstitutionsShares
Increased
159
4.10M
New
102
-113.67K
Decreased
159
3.93M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-0.61%
Healthcare Equipment & Supplies
-0.63%
Key Executives
Chairman/Independent Director
Timothy Scannell
Chairman/Independent Director
timothy Scannell
President/Chief Executive Officer/Director
Shacey Petrovic
Chief Financial Officer/Executive Vice President/Treasurer
Wayde McMillan
Chief Operating Officer/Executive Vice President
Charles Alpuche
Executive Vice President
Bret Christensen
Senior Vice President/General Counsel/Secretary
John Kapples
Senior Vice President
Eric Benjamin
Senior Vice President
Michael Spears
Director
Wayne Frederick
Independent Director
Sally Crawford
Independent Director
John Fallon
Independent Director
James Hollingshead
Independent Director
Jessica Hopfield
Independent Director
David Lemoine
Independent Director
Michael Minogue
Independent Director
Corinne Nevinny
  • Dividends
  • Splits
  • Insider Activity
No Data
  • All
  • Financials
  • Insiders
More
About PODD
Insulet Corporation is engaged in the development, manufacturing and sale of the OmniPod Insulin Management System (the OmniPod System), an insulin delivery system for people with insulin-dependent diabetes. The Omnipod System features a self-adhesive disposable tubeless Omnipod device, which is worn on the body for approximately three days at a time and its wireless companion, the handheld Personal Diabetes Manager (PDM). The Omnipod System features two discreet devices that eliminate the need for a bulky pump, tubing and separate blood glucose meter, provides for virtually pain-free automated cannula insertion, communicates wirelessly and integrates a blood glucose meter. The Omnipod System is a discreet two part design, the Omnipod device (Pod) and the PDM that eliminates the need for the external tubing required with conventional pumps. The Pod is a self-adhesive device that the patient fills with insulin and wears directly on the body.

Webull offers kinds of Insulet Corporation stock information, including NASDAQ:PODD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PODD stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading PODD stock methods without spending real money on the virtual paper trading platform.